1. Home
  2. RFL vs BRNS Comparison

RFL vs BRNS Comparison

Compare RFL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BRNS
  • Stock Information
  • Founded
  • RFL 2017
  • BRNS 2016
  • Country
  • RFL United States
  • BRNS United Kingdom
  • Employees
  • RFL N/A
  • BRNS N/A
  • Industry
  • RFL Real Estate
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RFL Finance
  • BRNS Health Care
  • Exchange
  • RFL Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • RFL 48.4M
  • BRNS 52.0M
  • IPO Year
  • RFL N/A
  • BRNS 2021
  • Fundamental
  • Price
  • RFL $2.00
  • BRNS $1.33
  • Analyst Decision
  • RFL
  • BRNS Strong Buy
  • Analyst Count
  • RFL 0
  • BRNS 2
  • Target Price
  • RFL N/A
  • BRNS $4.00
  • AVG Volume (30 Days)
  • RFL 47.3K
  • BRNS 17.4K
  • Earning Date
  • RFL 10-28-2024
  • BRNS 11-07-2024
  • Dividend Yield
  • RFL N/A
  • BRNS N/A
  • EPS Growth
  • RFL N/A
  • BRNS N/A
  • EPS
  • RFL N/A
  • BRNS N/A
  • Revenue
  • RFL $540,000.00
  • BRNS N/A
  • Revenue This Year
  • RFL N/A
  • BRNS $27.18
  • Revenue Next Year
  • RFL N/A
  • BRNS N/A
  • P/E Ratio
  • RFL N/A
  • BRNS N/A
  • Revenue Growth
  • RFL 92.86
  • BRNS N/A
  • 52 Week Low
  • RFL $1.29
  • BRNS $1.11
  • 52 Week High
  • RFL $2.14
  • BRNS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • RFL 74.68
  • BRNS 63.14
  • Support Level
  • RFL $1.65
  • BRNS $1.15
  • Resistance Level
  • RFL $1.94
  • BRNS $1.24
  • Average True Range (ATR)
  • RFL 0.10
  • BRNS 0.07
  • MACD
  • RFL 0.02
  • BRNS 0.01
  • Stochastic Oscillator
  • RFL 100.00
  • BRNS 100.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: